EPO and diabetic kidney disease: Impaired renal function due to hyperglycemia-induced reactive oxygen species (ROS) has been associated with a decline in erythropoietin concentration resulting from the destruction of interstitial fibroblasts responsible for erythropoietin secretion, which usually occurs during the onset of diabetic nephropathy [33]; [6].